Skip to main content

Day: February 18, 2026

Azimut Completes Galinée Property Transaction with LiFT Power, James Bay Region, Quebec

LONGUEUIL, Quebec, Feb. 18, 2026 (GLOBE NEWSWIRE) — Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) (OTCQX: AZMTF) announces the closing of the acquisition by LiFT Power Ltd. (“LiFT”) (TSXV: LIFT, OTCQX: LIFFF) of its 50% interest in the Galinée Property (the “Property”) located in the Eeyou Istchee James Bay region of Quebec. Under the acquisition agreement (the “Agreement”) announced on December 24, 2025 (see news releasei), LiFT acquired Azimut’s interest by issuing 2,000,000 common shares. Azimut was also granted a 1.4% NSR royalty on the Property, providing some long-term exposure to future developments. In addition, Azimut is entitled to a $1,500,000 deferred payment, payable in cash, or, subject to certain terms and conditions set out in the Agreement, in common shares of LiFT, at the earlier of 18 months...

Continue reading

CoinShares publishes the Scheme Circular in relation to joint merger plan

Jersey, Channel Islands, Feb. 18, 2026 (GLOBE NEWSWIRE) — 18 February 2026 | SAINT HELIER, Jersey | On 8 September 2025 CoinShares International Limited (“CoinShares”) (Nasdaq Stockholm: CS; US OTCQX: CNSRF) announced a joint merger plan with Vine Hill Capital Investment Corp (Nasdaq: VCIC) (“Vine Hill”) and Odysseus Holdings Limited (“Odysseus Holdings”), including a court-sanctioned scheme of arrangement under Article 125 of the Jersey Companies Law (“Scheme of Arrangement”) in order to facilitate a change of listing venue for CoinShares Shares from Nasdaq Stockholm to the Nasdaq Stock Market in the United States, or any other public stock market or exchange in the United States as may be agreed between CoinShares and Vine Hill (such joint merger plan and the Scheme of Arrangement being together the “Transaction”). Capitalised...

Continue reading

FLSmidth 2025 Annual Report: Solid performance provides strong foundation for the next phase, focused on accelerating growth

COMPANY ANNOUNCEMENT NO. 13-2026FLSmidth & Co. A/S18 February 2026Copenhagen, DenmarkToday, the Board of Directors of FLSmidth & Co. A/S (FLSmidth) have approved the 2025 Annual Report. In 2025, FLSmidth reported a total revenue DKK 14,612m and an Adjusted EBITA margin of 15.9%.Highlights in 2025:Order intake increased organically by 3% compared to 2024 driven by the Service and Pumps, Cyclones & Valves (PC&V) businesses. Total order intake decreased by 2% compared to 2024. Revenue decreased organically by 1% compared to 2024 driven by the Products business. Total revenue decreased by 7% compared to 2024. The Adjusted EBITA margin was 15.9% in 2025 compared to 11.3% in 2024. Net profit for the year amounted to DKK 8m compared to DKK 1,030m in 2024. The decline was driven by impairment of deferred tax assets in...

Continue reading

Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830

Press release – No. 4 / 2026 Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830Single doses of ZP9830 were well tolerated, with no serious or severe adverse events or dose-limiting safety findings observed at any dose level ZP9830 exhibited a pharmacokinetic profile in line with predictions based on preclinical data, and exploratory pharmacodynamic biomarkers showed robust, dose-dependent activity consistent with Kv1.3 target engagement ZP9830 is a highly potent and selective Kv1.3 channel blocker with potential to address a broad range of immune-mediated inflammatory disorders Development program is progressing rapidly and as planned, with Phase 1a multiple ascending dose data and Phase 1b/2a initiation expected in H2 2026Copenhagen, Denmark, February 18, 2026 – Zealand Pharma A/S (Nasdaq:...

Continue reading

Year-end Report 2025

HighlightsProportionate power generation amounted to 800 GWh for the year, with additional 39 GWh of compensated volumes from ancillary services and availability warranties, bringing the total proportionate power generation, including these volumes, to 839 GWh. Entered into agreements to sell a portfolio of three German solar projects totalling 234 MW in December 2025 for a total consideration of up to MEUR 14, subject to the achievement of development milestones, bringing the total project sales agreements signed during the year to MEUR 18, representing 310 MW of projects. Secured grid connections for six large-scale solar and data centre projects in the UK, with a combined estimated capacity of 2.9 GW, and successfully progressed solar projects in Germany with a combined capacity of 280 MW towards ready-to-permit following municipal...

Continue reading

Fiverr Announces Fourth Quarter and Full Year 2025 Results

Solid execution in 2025: 2025 was a year of disciplined execution, with revenue growing 10.1% year over year to $430.9 million and Adjusted EBITDA margin reaching 21.3%. We accelerated top-line growth compared to 2024 while maintaining strong profitability and cash generation. These results reflect the structural strength of our marketplace model and our continued financial discipline. Continued expansion into complex, high-value projects: Our marketplace continued to evolve toward high-value work. Spend per buyer increased 13.3% year over year, accelerating from the prior year, while GMV from transactions over $1,000 grew 22.8%. The number of buyers spending over $10,000 annually also accelerated 7%. These trends validate our upmarket strategy and demonstrate the growing adoption of Dynamic Matching and Managed Services, enabling us...

Continue reading

IMCD reports EBITA of EUR 498 million in 2025

Rotterdam, The Netherlands (18 February 2026) – IMCD N.V. (“IMCD” or “Company”), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces its full-year 2025 results. HIGHLIGHTS• Revenue at EUR 4,779 million (+5% on a constant currency basis)• Gross profit at EUR 1,194 million (+3% on a constant currency basis)• Operating EBITA at EUR 498 million (-3% on a constant currency basis)• Free cash flow up by 3% to EUR 465 million (2024: EUR 450 million)• Cash earnings per share at EUR 5.19 (2024: EUR 6.34)• Dividend proposal of EUR 1.81 in cash per share (2024: EUR 2.15)• Successful completion of 7 acquisitions across all our regions in 2025 Marcus Jordan, CEO: “After a good first quarter, the following quarters of 2025 were challenging amid macroeconomic...

Continue reading

Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)

Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1Remibrutinib, a highly selective oral BTK inhibitor, was well-tolerated and demonstrated a favorable safety profile, including no liver safety concerns1Oral remibrutinib has potential to be first targeted therapy approved for CIndU, which affects estimated 29 million adults worldwide2,3Basel, February 18, 2026 – Novartis today announced positive topline results from its pivotal Phase III RemIND trial of oral remibrutinib in chronic inducible urticaria (CIndU)1. The primary endpoint was met for the three most prevalent types of CIndU: symptomatic dermographism, cold urticaria and cholinergic urticaria, achieving significantly higher complete response rates versus placebo at Week 121. These data represent...

Continue reading

Hepsor AS consolidated unaudited interim report for Q4 2025 and twelve months

The Group’s consolidated revenue for the fourth quarter of 2025 amounted to 4.5 million euros (Q4 2024: 10.5 million euros), while the consolidated revenue for the reporting year was 35.4 million  euros (2024: 38.4 million euros). The Group recorded a net loss of  0.5 million euros for the fourth quarter (Q4 2024: net profit of 1.0 million euros), of which the net loss attributable to the owners of the parent company was 0.5 million  euros (Q4 2024: net profit of 1.0 million euros). The Group’s net profit for 2025 was 1.0 million euros (2024: 2.1 million euros). The net profit attributable to the owners of the parent company for the reporting year was 0.4 million euros (2024:  0.4 million euros). Compared with the previous year, the Group’s revenue and profitability in 2025 were affected by a decrease in the number of apartments handed...

Continue reading

Getty Realty Corp. Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) — Getty Realty Corp. (NYSE: GTY) (the “Company”), a net lease REIT focused on convenience and automotive retail real estate, today announced the pricing of an underwritten public offering of an aggregate of 4,000,000 shares of its common stock sold on a forward basis in connection with the forward sale agreements described below, for gross proceeds of approximately $131 million. The forward purchasers (or their affiliates) and the Company have also granted the underwriters of the offering a 30-day option to purchase up to an additional 600,000 shares of common stock. The offering is expected to close on February 19, 2026, subject to customary closing conditions. J.P. Morgan and Wells Fargo Securities acted as book-running managers for the offering. In connection with the offering of shares...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.